Zacks: Brokerages Expect Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) to Announce $0.22 EPS

Brokerages expect Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRXGet Rating) to post $0.22 earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Three analysts have provided estimates for Allscripts Healthcare Solutions’ earnings. The lowest EPS estimate is $0.21 and the highest is $0.24. Allscripts Healthcare Solutions posted earnings of $0.19 per share during the same quarter last year, which would indicate a positive year-over-year growth rate of 15.8%. The company is expected to announce its next earnings results on Monday, January 1st.

On average, analysts expect that Allscripts Healthcare Solutions will report full-year earnings of $1.01 per share for the current financial year, with EPS estimates ranging from $0.91 to $1.12. For the next year, analysts forecast that the company will report earnings of $1.09 per share, with EPS estimates ranging from $1.00 to $1.22. Zacks’ EPS averages are a mean average based on a survey of research analysts that that provide coverage for Allscripts Healthcare Solutions.

Allscripts Healthcare Solutions (NASDAQ:MDRXGet Rating) last posted its quarterly earnings data on Thursday, February 24th. The software maker reported $0.72 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.25 by $0.47. The firm had revenue of $391.70 million during the quarter, compared to the consensus estimate of $390.63 million. Allscripts Healthcare Solutions had a return on equity of 10.91% and a net margin of 8.94%. The firm’s revenue was up 1.4% compared to the same quarter last year. During the same period in the prior year, the business earned $0.24 EPS.

A number of equities research analysts have weighed in on the company. SVB Leerink lifted their price objective on Allscripts Healthcare Solutions from $22.00 to $24.00 and gave the company an “outperform” rating in a report on Thursday, March 3rd. Piper Sandler upped their target price on shares of Allscripts Healthcare Solutions from $19.00 to $22.00 and gave the stock a “neutral” rating in a research report on Friday, March 18th. StockNews.com raised shares of Allscripts Healthcare Solutions from a “hold” rating to a “buy” rating in a report on Friday, April 8th. Zacks Investment Research lowered Allscripts Healthcare Solutions from a “buy” rating to a “hold” rating and set a $23.00 target price on the stock. in a report on Tuesday, March 29th. Finally, Deutsche Bank Aktiengesellschaft upgraded shares of Allscripts Healthcare Solutions from a “hold” rating to a “buy” rating and lifted their target price for the stock from $20.00 to $26.00 in a research report on Friday, March 4th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, Allscripts Healthcare Solutions has an average rating of “Hold” and an average price target of $22.50.

In other news, CEO Paul Black sold 60,000 shares of the company’s stock in a transaction dated Thursday, March 10th. The shares were sold at an average price of $21.87, for a total transaction of $1,312,200.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Richard J. Poulton sold 10,000 shares of the stock in a transaction dated Tuesday, February 15th. The stock was sold at an average price of $20.83, for a total transaction of $208,300.00. The disclosure for this sale can be found here. Insiders own 1.91% of the company’s stock.

A number of large investors have recently bought and sold shares of the business. Nordea Investment Management AB raised its holdings in shares of Allscripts Healthcare Solutions by 5.1% in the 1st quarter. Nordea Investment Management AB now owns 127,758 shares of the software maker’s stock worth $2,900,000 after purchasing an additional 6,242 shares during the period. Norges Bank acquired a new stake in shares of Allscripts Healthcare Solutions in the fourth quarter worth $16,809,000. Barclays PLC increased its position in shares of Allscripts Healthcare Solutions by 0.6% in the fourth quarter. Barclays PLC now owns 280,554 shares of the software maker’s stock worth $5,177,000 after acquiring an additional 1,547 shares in the last quarter. BlackRock Inc. raised its stake in shares of Allscripts Healthcare Solutions by 9.3% in the 4th quarter. BlackRock Inc. now owns 23,846,502 shares of the software maker’s stock valued at $439,969,000 after acquiring an additional 2,028,119 shares during the period. Finally, Vident Investment Advisory LLC lifted its holdings in shares of Allscripts Healthcare Solutions by 4.0% during the 4th quarter. Vident Investment Advisory LLC now owns 112,737 shares of the software maker’s stock valued at $2,080,000 after acquiring an additional 4,382 shares in the last quarter. 96.40% of the stock is currently owned by institutional investors.

Shares of Allscripts Healthcare Solutions stock traded up $0.46 on Wednesday, reaching $22.80. 1,335,284 shares of the stock were exchanged, compared to its average volume of 1,875,369. Allscripts Healthcare Solutions has a 1-year low of $13.05 and a 1-year high of $23.24. The company has a current ratio of 1.39, a quick ratio of 1.39 and a debt-to-equity ratio of 0.25. The business has a fifty day moving average price of $21.59 and a two-hundred day moving average price of $18.54. The firm has a market capitalization of $2.79 billion, a PE ratio of 22.57, a PEG ratio of 1.81 and a beta of 0.98.

Allscripts Healthcare Solutions Company Profile (Get Rating)

Allscripts Healthcare Solutions, Inc, together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Further Reading

Get a free copy of the Zacks research report on Allscripts Healthcare Solutions (MDRX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.